GlycoMimetics Stock: High Risk/Reward Opportunity With a Near-Term Catalyst (GLYC)




Topline Summary and Update

GlycoMimetics (NASDAQ:GLYC) is working on molecules that take advantage of cell biology’s peculiar reliance on specific carbohydrate groups in the battle against cancer. When I covered them previously, I highlighted concerns I


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *